News
Media
Conferences
Publication
Job Board
CME/CE
Partners
Editorial
Resources
Subscribe

Spotlight -

Long-Acting Injectable Therapy in the Management of Adult Patients with Schizophrenia|

Major Depressive Disorder

Kaamil Abid, MD

Dr Abid is a first-year psychiatry resident at Creighton University.

Articles by Kaamil Abid, MD

borderline personality disorder

Comparing SSRI Treatment and DBT for Managing Suicidality in Patients With Borderline Personality Disorder

ByLior Hilsenrath, MD,Orrin Chambers, DO,Kaamil Abid, MD,Albert Dickan, MD,Haley Schuster, MD,Mark Mullen, MD,Rajesh R. Tampi, MD, MS, DFAPA, DFAAGP

March 5th 2026

New RCT shows DBT cuts suicidal crises and self-harm in borderline personality disorder more than SSRIs, though benefits fade after treatment.

Latest Updated Articles

Comparing SSRI Treatment and DBT for Managing Suicidality in Patients With Borderline Personality Disorder
March 5th 2026

Trending on Psychiatric Times

Zolpidem: Restoring Sleep and Slowing Alzheimer Disease Progression

Treating Patients With First-Episode Psychosis: Lessons From McLean OnTrack

Sleep, Cognition, and the Bidirectional Brain, With Michael Scullin, PhD

Transcranial Direct Current Stimulation to Enhance Brain Activity: Applicability for Schizophrenia

How Sleep Conditions Predict the Likelihood and Severity of Falls in Older Adults